UAMS to offer 3rd dose of COVID-19 vaccine to moderately, severely immunocompromised patients


LITTLE ROCK, Ark. —The University of Arkansas for Medical Sciences will offer a third dose of the COVID-19 vaccine to its moderately and severely immunocompromised patients beginning on Monday, Aug. 16.

Appointments are required.

Under guidelines issued by the Federal Drug Administration, only patients who received the two-shot Pfizer or Moderna vaccines and who meet the definition of moderately or severely immunocompromised are eligible for a third dose. The third dose should be the same vaccine the patient received earlier.

UAMS patients eligible for a COVID booster include:

  • Those in active treatment for solid tumor and hematologic malignancies
  • Transplant patients who are taking immunosuppressive therapy
  • Those who have received CAR-T cell therapy or a stem cell transplant (within two years of transplantation or still taking immunosuppressive therapy)
  • Those with advanced or untreated HIV infection
  • Those undergoing active treatment with high-dose corticosteroids and other pharmaceuticals that are immunosuppressive or immunomodulatory

Existing UAMS patients should contact their physician to see if they are eligible for a booster and to schedule an appointment.

Copyright 2021 Nexstar Media Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Trending Stories